Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study

INTRODUCTION: Bronchodilators, including long-acting muscarinic antagonists (LAMA) and long-acting beta 2 agonists (LABA), are the main treatments for chronic obstructive pulmonary disease (COPD). The efficacy of triple therapy (inhaled corticosteroids/LAMA/LABA) has also been reported. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Koichiro, Kawayama, Tomotaka, Takamori, Ayako, Tashiro, Hiroki, Kinoshita, Takashi, Takagi, Koichi, Yamasaki, Kei, Machida, Kentaro, Kawaguchi, Atsushi, Yatera, Kazuhiro, Inoue, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441813/
https://www.ncbi.nlm.nih.gov/pubmed/37197795
http://dx.doi.org/10.1136/bmjresp-2022-001607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441813/
https://www.ncbi.nlm.nih.gov/pubmed/37197795
http://dx.doi.org/10.1136/bmjresp-2022-001607

Ejemplares similares